Medtronic Receives FDA Approval for CareLink SmartSync Device Manager

11:00 EDT 2 May 2019 | GlobalNewsWire (2014)
This article has expired, however you can still download the PDF.
Tablet-Based Device Manager Provides Portable and Secure Wireless Programming of Medtronic BlueSync(TM) Devices DUBLIN - May 2, 2019 - Medtronic plc (NYSE:MDT) today announced that the company has received U.S. Food and Drug Administration...

Other Sources for this Article


More From BioPortfolio on "Medtronic Receives FDA Approval for CareLink SmartSync Device Manager"

Quick Search

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...